InvestSMART

ECS Botanics Holdings Ltd (ASX: ECS) - Announcements

- Current share price for ECS : $0.005

ASX company news and announcements for ECS Botanics Holdings Ltd (ECS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ECS Botanics Holdings Ltd (ECS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ECS Botanics Holdings Ltd (ECS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ECS Botanics Holdings Ltd (ECS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$8 Change of Director's Interest Notice X3 4 Nov 2022 8:24AM $0.024 $0.005 fallen by 79.17%
$8 Notification regarding unquoted securities - ECS 4 Nov 2022 8:19AM $0.024 $0.005 fallen by 79.17%
$8 Notification of cessation of securities - ECS 4 Nov 2022 8:19AM $0.024 $0.005 fallen by 79.17%
$8 Constitution 28 Oct 2022 2:45PM $0.023 $0.005 fallen by 78.26%
$8 Results of Annual General Meeting 26 Oct 2022 3:10PM $0.022 $0.005 fallen by 77.27%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 26 Oct 2022 8:58AM $0.022 $0.005 fallen by 77.27%
$8 Sale of Tasmanian Assets 24 Oct 2022 8:40AM $0.021 $0.005 fallen by 76.19%
$8 AGM Letter to Shareholders 23 Sep 2022 8:07AM $0.022 $0.005 fallen by 77.27%
$8 Notice of Annual General Meeting/Proxy Form 23 Sep 2022 8:07AM $0.022 $0.005 fallen by 77.27%
$8 Appendix 4G and Corporate Governance Statement 23 Sep 2022 8:07AM $0.022 $0.005 fallen by 77.27%
$8 Annual Report to shareholders 23 Sep 2022 8:07AM $0.022 $0.005 fallen by 77.27%
$8 Appendix 4E Preliminary Final Report 1 Sep 2022 8:25AM $0.026 $0.005 fallen by 80.77%
$8 AGM Date and Closing Date for Director Nominations 26 Aug 2022 12:57PM $0.029 $0.005 fallen by 82.46%
$8 Office of Drug Control Approves Expansion 22 Aug 2022 9:06AM $0.029 $0.005 fallen by 82.76%
$8 Notification regarding unquoted securities - ECS 16 Aug 2022 10:02AM $0.027 $0.005 fallen by 81.48%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 25 Jul 2022 9:30AM $0.026 $0.005 fallen by 80.77%
$8 Non-dilutive funding and asset sale update 22 Jul 2022 8:20AM $0.027 $0.005 fallen by 81.48%
$8 Investor Presentation 6 Jul 2022 9:03AM $0.020 $0.005 fallen by 75%
$8 ECS Exports First Shipment to New Zealand 4 Jul 2022 9:04AM $0.018 $0.005 fallen by 72.22%
$8 Change of Director's Interest Notice 27 Jun 2022 11:10AM $0.016 $0.005 fallen by 68.75%
$8 Focussed Strategy to Maximise Growth 14 Jun 2022 9:09AM $0.017 $0.005 fallen by 70.59%
$8 Final Director's Interest Notice 14 Jun 2022 8:21AM $0.017 $0.005 fallen by 70.59%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 26 Apr 2022 9:35AM $0.027 $0.005 fallen by 81.48%
$8 Change of Director's Interest Notice 5 Apr 2022 8:29AM $0.029 $0.005 fallen by 82.76%
$8 Marketing, Operational & Revenue Update 8 Mar 2022 9:56AM $0.025 $0.005 fallen by 80%

176 - 200 of 425 results

Page 8 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.